Theratechnologies Management
Management criteria checks 3/4
Theratechnologies' CEO is Paul Lévesque, appointed in Apr 2020, has a tenure of 4.17 years. total yearly compensation is $1.90M, comprised of 34.7% salary and 65.3% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth $93.30K. The average tenure of the management team and the board of directors is 6 years and 3.9 years respectively.
Key information
Paul Lévesque
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 34.7% |
| CEO tenure | 4.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 6yrs |
| Board average tenure | 3.9yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Feb 29 2024 | n/a | n/a | -US$18m |
| Nov 30 2023 | US$2m | US$659k | -US$24m |
| Aug 31 2023 | n/a | n/a | -US$29m |
| May 31 2023 | n/a | n/a | -US$36m |
| Feb 28 2023 | n/a | n/a | -US$49m |
| Nov 30 2022 | US$2m | US$657k | -US$47m |
| Aug 31 2022 | n/a | n/a | -US$49m |
| May 31 2022 | n/a | n/a | -US$51m |
| Feb 28 2022 | n/a | n/a | -US$35m |
| Nov 30 2021 | US$2m | US$639k | -US$32m |
| Aug 31 2021 | n/a | n/a | -US$27m |
| May 31 2021 | n/a | n/a | -US$25m |
| Feb 28 2021 | n/a | n/a | -US$24m |
| Nov 30 2020 | US$2m | US$379k | -US$23m |
Compensation vs Market: Paul's total compensation ($USD1.90M) is above average for companies of similar size in the US market ($USD667.49K).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Lévesque (60 yo)
4.2yrs
Tenure
US$1,900,415
Compensation
Mr. Paul Lévesque has been President, Chief Executive Officer and Director at Theratechnologies Inc. since April 6, 2020. Mr. Lévesque boasts many years of experience in the pharmaceutical field. After beg...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.2yrs | US$1.90m | 0.16% $ 93.3k | |
| Senior VP & CFO | 8.3yrs | US$654.50k | 0.034% $ 20.2k | |
| General Counsel & Corporate Secretary | 17.2yrs | US$468.88k | 0.0098% $ 5.8k | |
| Senior VP & Chief Medical Officer | 7.9yrs | US$656.79k | 0.032% $ 19.0k | |
| Global Commercial Officer | 3.3yrs | US$604.30k | 0.11% $ 65.7k | |
| Vice President of Human Resources | 3.1yrs | no data | no data |
6.0yrs
Average Tenure
59.5yo
Average Age
Experienced Management: THTX's management team is seasoned and experienced (6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.2yrs | US$1.90m | 0.16% $ 93.3k | |
| Independent Chairman | 3yrs | US$65.48k | 0.13% $ 76.6k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.7yrs | US$64.00k | 0.30% $ 176.2k | |
| Independent Director | 11.2yrs | US$141.74k | 0.24% $ 142.1k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 7.1yrs | US$66.96k | 0.096% $ 56.6k | |
| Independent Director | 3.1yrs | US$61.31k | 0.030% $ 17.6k |
3.9yrs
Average Tenure
67.5yo
Average Age
Experienced Board: THTX's board of directors are considered experienced (3.9 years average tenure).